3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with 6-ketoprostaglandin f1 alpha in 5 studies
Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
36 | 1 | 1 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooley, AJ; Culham, CA; Frisbie, DD; Grauer, GF; Johnson, HC; Longhofer, SL; Schultz, KT | 1 |
Anderson, C; Brunt, E; Jendrisak, M; Mangino, M; Murphy, M; Sicard, G; Tobimatsu, M | 1 |
Chaland, P; Corman, J; Daloze, P; Douglas, F; Etienne, P; Giroux, L; Moutquin, JM; Smeesters, C; St-Louis, G | 2 |
Bearn, PE; Bull, H; Marston, A; McCollum, CN; Seddon, AM | 1 |
5 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Concanavalin A; Dinoprostone; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glomerulonephritis; Immune Complex Diseases; Kidney; Kidney Glomerulus; Male; Pyridines; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1991 |
Thromboxane synthesis inhibition and renal allograft function.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dogs; Glomerular Filtration Rate; In Vitro Techniques; Kidney; Kidney Transplantation; Pyridines; Renal Circulation; Thromboxane B2; Thromboxane-A Synthase; Transplantation, Autologous; Transplantation, Homologous | 1989 |
Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Creatinine; Cyclosporins; Dinoprostone; Kidney Diseases; Male; Prostaglandins E; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Creatinine; Cyclosporins; Dinoprostone; Kidney; Prostaglandins E; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase | 1988 |
The effect of platelet inhibitory therapy on graft thromboresistance.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Vessel Prosthesis; Dipyridamole; Dogs; Drug Therapy, Combination; Female; Femoral Artery; Graft Occlusion, Vascular; Pyridines; Radiography; Random Allocation; Thromboxane-A Synthase | 1993 |